These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 15845258)
1. A human papillomavirus type 16 vaccine by oral delivery of L1 protein. Sasagawa T; Tani M; Basha W; Rose RC; Tohda H; Giga-Hama Y; Azar KK; Yasuda H; Sakai A; Inoue M Virus Res; 2005 Jun; 110(1-2):81-90. PubMed ID: 15845258 [TBL] [Abstract][Full Text] [Related]
2. Enhanced mucosal and systemic immunogenicity of human papillomavirus-like particles encapsidating interleukin-2 gene adjuvant. Oh YK; Sohn T; Park JS; Kang MJ; Choi HG; Kim JA; Kim WK; Ko JJ; Kim CK Virology; 2004 Oct; 328(2):266-73. PubMed ID: 15464846 [TBL] [Abstract][Full Text] [Related]
3. Human papillomavirus virus-like particles are efficient oral immunogens when coadministered with Escherichia coli heat-labile enterotoxin mutant R192G or CpG DNA. Gerber S; Lane C; Brown DM; Lord E; DiLorenzo M; Clements JD; Rybicki E; Williamson AL; Rose RC J Virol; 2001 May; 75(10):4752-60. PubMed ID: 11312347 [TBL] [Abstract][Full Text] [Related]
4. Enhanced mucosal and systemic immune responses following intravaginal immunization with human papillomavirus 16 L1 virus-like particle vaccine in thermosensitive mucoadhesive delivery systems. Park JS; Oh YK; Kang MJ; Kim CK J Med Virol; 2003 Aug; 70(4):633-41. PubMed ID: 12794729 [TBL] [Abstract][Full Text] [Related]
5. Durable immunity to oncogenic human papillomaviruses elicited by adjuvanted recombinant Adeno-associated virus-like particle immunogen displaying L2 17-36 epitopes. Jagu S; Karanam B; Wang JW; Zayed H; Weghofer M; Brendle SA; Balogh KK; Tossi KP; Roden RBS; Christensen ND Vaccine; 2015 Oct; 33(42):5553-5563. PubMed ID: 26382603 [TBL] [Abstract][Full Text] [Related]
6. Transgenic tobacco expressed HPV16-L1 and LT-B combined immunization induces strong mucosal and systemic immune responses in mice. Hongli L; Xukui L; Ting L; Wensheng L; Lusheng S; Jin Z Hum Vaccin Immunother; 2013 Jan; 9(1):83-9. PubMed ID: 23108357 [TBL] [Abstract][Full Text] [Related]
7. Rectal and vaginal immunization of mice with human papillomavirus L1 virus-like particles. Fraillery D; Zosso N; Nardelli-Haefliger D Vaccine; 2009 Apr; 27(17):2326-34. PubMed ID: 19428847 [TBL] [Abstract][Full Text] [Related]
8. HPV16L1-attenuated Shigella recombinant vaccine induced strong vaginal and systemic immune responses in guinea pig model. Yan X; Wang D; Liang F; Fu L; Guo C Hum Vaccin Immunother; 2014; 10(12):3491-8. PubMed ID: 25483698 [TBL] [Abstract][Full Text] [Related]
9. Nasal immunization of mice with human papillomavirus type 16 (HPV-16) virus-like particles or with the HPV-16 L1 gene elicits specific cytotoxic T lymphocytes in vaginal draining lymph nodes. Dupuy C; Buzoni-Gatel D; Touzé A; Bout D; Coursaget P J Virol; 1999 Nov; 73(11):9063-71. PubMed ID: 10516012 [TBL] [Abstract][Full Text] [Related]
10. Nasal immunization of mice with human papillomavirus type 16 virus-like particles elicits neutralizing antibodies in mucosal secretions. Balmelli C; Roden R; Potts A; Schiller J; De Grandi P; Nardelli-Haefliger D J Virol; 1998 Oct; 72(10):8220-9. PubMed ID: 9733865 [TBL] [Abstract][Full Text] [Related]
11. Human papillomavirus type 16 virus-like particles expressed in attenuated Salmonella typhimurium elicit mucosal and systemic neutralizing antibodies in mice. Nardelli-Haefliger D; Roden RB; Benyacoub J; Sahli R; Kraehenbuhl JP; Schiller JT; Lachat P; Potts A; De Grandi P Infect Immun; 1997 Aug; 65(8):3328-36. PubMed ID: 9234794 [TBL] [Abstract][Full Text] [Related]
12. Comparison of the immune responses to the CIA06-adjuvanted human papillomavirus L1 VLP vaccine with those against the licensed HPV vaccine Cervarix™ in mice. Han JE; Wui SR; Park SA; Lee NG; Kim KS; Cho YJ; Kim HJ; Kim HJ Vaccine; 2012 Jun; 30(28):4127-34. PubMed ID: 22561312 [TBL] [Abstract][Full Text] [Related]
13. Enhanced humoral and memory B cellular immunity using HPV16/18 L1 VLP vaccine formulated with the MPL/aluminium salt combination (AS04) compared to aluminium salt only. Giannini SL; Hanon E; Moris P; Van Mechelen M; Morel S; Dessy F; Fourneau MA; Colau B; Suzich J; Losonksy G; Martin MT; Dubin G; Wettendorff MA Vaccine; 2006 Aug; 24(33-34):5937-49. PubMed ID: 16828940 [TBL] [Abstract][Full Text] [Related]
15. Intranasal vaccination with recombinant adeno-associated virus type 5 against human papillomavirus type 16 L1. Kuck D; Lau T; Leuchs B; Kern A; Müller M; Gissmann L; Kleinschmidt JA J Virol; 2006 Mar; 80(6):2621-30. PubMed ID: 16501072 [TBL] [Abstract][Full Text] [Related]
16. Improved efficiency of a Salmonella-based vaccine against human papillomavirus type 16 virus-like particles achieved by using a codon-optimized version of L1. Baud D; Ponci F; Bobst M; De Grandi P; Nardelli-Haefliger D J Virol; 2004 Dec; 78(23):12901-9. PubMed ID: 15542642 [TBL] [Abstract][Full Text] [Related]
17. Capsid display of a conserved human papillomavirus L2 peptide in the adenovirus 5 hexon protein: a candidate prophylactic hpv vaccine approach. Wu WH; Alkutkar T; Karanam B; Roden RB; Ketner G; Ibeanu OA Virol J; 2015 Sep; 12():140. PubMed ID: 26362430 [TBL] [Abstract][Full Text] [Related]
18. Broad Cross-Protection Is Induced in Preclinical Models by a Human Papillomavirus Vaccine Composed of L1/L2 Chimeric Virus-Like Particles. Boxus M; Fochesato M; Miseur A; Mertens E; Dendouga N; Brendle S; Balogh KK; Christensen ND; Giannini SL J Virol; 2016 Jul; 90(14):6314-25. PubMed ID: 27147749 [TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus type 16 L1 capsomeres induce L1-specific cytotoxic T lymphocytes and tumor regression in C57BL/6 mice. Ohlschläger P; Osen W; Dell K; Faath S; Garcea RL; Jochmus I; Müller M; Pawlita M; Schäfer K; Sehr P; Staib C; Sutter G; Gissmann L J Virol; 2003 Apr; 77(8):4635-45. PubMed ID: 12663770 [TBL] [Abstract][Full Text] [Related]
20. Parenteral and oral immunization with a plasmid DNA expressing the human papillomavirus 16-L1 gene induces systemic and mucosal antibodies and cytotoxic T lymphocyte responses. Rocha-Zavaleta L; Alejandre JE; Garcia-Carranca A J Med Virol; 2002 Jan; 66(1):86-95. PubMed ID: 11748663 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]